Expert Opinion on Investigational Drugs (ISSN 1354-3784 [print], 1744-7658 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on drugs in preclinical and early stage clinical development, providing expert opinion on the scope for future development.
The Editors welcome:
/// Reviews covering preclinical through to Phase II data on drugs or drug classes for specific indications, and their potential impact on future treatment strategies
/// Drug Evaluations reviewing the clinical and pharmacological data on a particular drug
/// Original Research papers reporting the results of clinical investigations on agents that are in Phase I and II clinical trials
The audience consists of scientists, managers and decision-makers in the pharmaceutical industry, and others closely involved in R&D.
Yu, Kyung-Sang; Kim, Byungwook; Shin, Dongseong; Park, Min Kyu; Hwang, Jun Gi; Kim, Min-Gul; Chung, Hyewon; Ghim, JongLyul; Chung, Jae-Yong; Smolen, Josef S., et al.
ArticleIssue Date2023CitationEXPERT OPINION ON INVESTIGATIONAL DRUGS, v.32, no.5, pp.429 - 439PublisherTAYLOR & FRANCIS LTD